These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

502 related articles for article (PubMed ID: 24738483)

  • 1. Glucocorticoids in juvenile idiopathic arthritis.
    Malattia C; Martini A
    Ann N Y Acad Sci; 2014 May; 1318():65-70. PubMed ID: 24738483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile idiopathic arthritis in the new world of biologics.
    Ostring GT; Singh-Grewal D
    J Paediatr Child Health; 2013 Sep; 49(9):E405-12. PubMed ID: 23647810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent therapeutic advances in juvenile idiopathic arthritis.
    Giancane G; Alongi A; Rosina S; Tibaldi J; Consolaro A; Ravelli A
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):476-487. PubMed ID: 29773268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoids in juvenile idiopathic arthritis.
    Schiappapietra B; Varnier G; Rosina S; Consolaro A; Martini A; Ravelli A
    Neuroimmunomodulation; 2015; 22(1-2):112-8. PubMed ID: 25227183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans.
    Kimura Y; Grevich S; Beukelman T; Morgan E; Nigrovic PA; Mieszkalski K; Graham TB; Ibarra M; Ilowite N; Klein-Gitelman M; Onel K; Prahalad S; Punaro M; Ringold S; Toib D; Van Mater H; Weiss JE; Weiss PF; Schanberg LE;
    Pediatr Rheumatol Online J; 2017 Apr; 15(1):23. PubMed ID: 28399931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucocorticoid treatment in juvenile idiopathic arthritis.
    Batu ED
    Rheumatol Int; 2019 Jan; 39(1):13-27. PubMed ID: 30276425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Juvenile idiopathic arthritis (JIA): a screening study to measure class II skeletal pattern, TMJ PDS and use of systemic corticosteroids.
    Mandall NA; Gray R; O'Brien KD; Baildam E; Macfarlane TV; Davidson J; Sills J; Foster H; Gardner-Medwin J; Garrahy A; Millett D; Mattick R; Walsh T; Ward S
    J Orthod; 2010 Mar; 37(1):6-15. PubMed ID: 20439922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of methotrexate response in Turkish children with oligoarticular and polyarticular juvenile idiopathic arthritis.
    Batu ED; Sönmez HE; Gülhan B; Arıcı ZS; Topaloğlu R; Bilginer Y
    Turk J Pediatr; 2017; 59(1):6-12. PubMed ID: 29168357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate: new uses for an old drug.
    Hashkes PJ; Becker ML; Cabral DA; Laxer RM; Paller AS; Rabinovich CE; Turner D; Zulian F
    J Pediatr; 2014 Feb; 164(2):231-6. PubMed ID: 24286573
    [No Abstract]   [Full Text] [Related]  

  • 10. Macrophage activation syndrome as the initial manifestation of systemic onset juvenile idiopathic arthritis.
    Cuende E; Vesga JC; Pérez LB; Ardanaz MT; Guinea J
    Clin Exp Rheumatol; 2001; 19(6):764-5. PubMed ID: 11791663
    [No Abstract]   [Full Text] [Related]  

  • 11. Development of pylomatrixoma after the subcutaneous injection of methotrexate for the treatment of juvenile idiopathic arthritis.
    Afonso Pérez E; Garcia Porrua C; Castiñeiras Mato IM; Bal Nieves F
    Reumatol Clin; 2012; 8(6):380-1. PubMed ID: 22858519
    [No Abstract]   [Full Text] [Related]  

  • 12. Juvenile Idiopathic Arthritis.
    Barut K; Adrovic A; Şahin S; Kasapçopur Ö
    Balkan Med J; 2017 Apr; 34(2):90-101. PubMed ID: 28418334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the treatment of juvenile idiopathic arthritis.
    Harris JG; Kessler EA; Verbsky JW
    Curr Allergy Asthma Rep; 2013 Aug; 13(4):337-46. PubMed ID: 23605168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Juvenile idiopathic arthritis: updated guide to administering methotrexate.
    Livermore P
    Nurs Child Young People; 2014 Feb; 26(1):26-9. PubMed ID: 24517621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment strategies for juvenile idiopathic arthritis.
    Klein A; Horneff G
    Expert Opin Pharmacother; 2009 Dec; 10(18):3049-60. PubMed ID: 19954274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of treatment with immunomodulatory therapy in patients with corticosteroid-resistant juvenile idiopathic arthritis-associated chronic iridocyclitis.
    Yu EN; Meniconi ME; Tufail F; Baltatzis S; Foster CS
    Ocul Immunol Inflamm; 2005; 13(5):353-60. PubMed ID: 16419420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical treatment of juvenile idiopathic arthritis.
    Hashkes PJ; Laxer RM
    JAMA; 2005 Oct; 294(13):1671-84. PubMed ID: 16204667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologics in juvenile idiopathic arthritis: a narrative review.
    Vanoni F; Minoia F; Malattia C
    Eur J Pediatr; 2017 Sep; 176(9):1147-1153. PubMed ID: 28725955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Judicious use of biologicals in juvenile idiopathic arthritis.
    Zhao Y; Wallace C
    Curr Rheumatol Rep; 2014 Nov; 16(11):454. PubMed ID: 25218736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methotrexate for uveitis associated with juvenile idiopathic arthritis: value and requirement for additional anti-inflammatory medication.
    Heiligenhaus A; Mingels A; Heinz C; Ganser G
    Eur J Ophthalmol; 2007; 17(5):743-8. PubMed ID: 17932849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.